GlassScriptPhysician profile
Charles L Roeth
NPI 1295787653
$1,099.37
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $51.55 · 2021: $329 · 2022: $171 · 2023: $182 · 2024: $64.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $217.38 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $187.86 | 2019-2024 | |
| Abiomed | $139.90 | 2021 | |
| Medtronic Vascular, INC. | $125.66 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $116.91 | 2023-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.11 | 2020-2022 | |
| Pfizer INC. | $43.51 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $36.86 | 2021 | |
| Amgen INC. | $36.05 | 2019 | |
| Abbott Laboratories | $29.34 | 2019 | |
| Boston Scientific Corporation | $28.55 | 2023 | Watchman Access System |
| Lundbeck LLC | $19.90 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.76 | 2019 | |
| Cook Medical LLC | $12.78 | 2023 | Evolution |
| Arbor Pharmaceuticals, INC. | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Roeth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.